Cerevance
Phase 3Welcome to the CNS revolution. Cerevance is a revolutionary pharmaceutical company using the proprietary NETSseq platform to develop novel symptomatic and disease modifying therapies for CNS disorders
Founded
2016
Focus
Small Molecules
About
Welcome to the CNS revolution. Cerevance is a revolutionary pharmaceutical company using the proprietary NETSseq platform to develop novel symptomatic and disease modifying therapies for CNS disorders
Funding History
3Total raised: $196M
Series C$116MGVJun 15, 2022
Series B$51MLightstone VenturesJun 15, 2020
Series A$29MSR OneJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationBoston, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile